LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
USA - NASDAQ:LMAT - US5255582018 - Common Stock
88.44 USD
-1.2 (-1.34%)
88.44 USD
0 (0%)
We assign a fundamental rating of 7 out of 10 to LMAT. LMAT was compared to 189 industry peers in the Health Care Equipment & Supplies industry. LMAT scores excellent points on both the profitability and health parts. This is a solid base for a good stock. LMAT is not valued too expensively and it also shows a decent growth rate. These ratings could make LMAT a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
In the past year LMAT had a positive cash flow from operations.
In the past 5 years LMAT has always been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
LMAT has a better Return On Assets (8.16%) than 90.48% of its industry peers.
Looking at the Return On Equity, with a value of 12.99%, LMAT belongs to the top of the industry, outperforming 88.36% of the companies in the same industry.
With an excellent Return On Invested Capital value of 7.70%, LMAT belongs to the best of the industry, outperforming 84.13% of the companies in the same industry.
LMAT had an Average Return On Invested Capital over the past 3 years of 8.26%. This is in line with the industry average of 8.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROIC | 7.7% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
The Profit Margin of LMAT (20.08%) is better than 93.12% of its industry peers.
In the last couple of years the Profit Margin of LMAT has grown nicely.
Looking at the Operating Margin, with a value of 23.34%, LMAT belongs to the top of the industry, outperforming 94.71% of the companies in the same industry.
LMAT's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 69.11%, LMAT is doing good in the industry, outperforming 76.19% of the companies in the same industry.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LMAT is destroying value.
LMAT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LMAT has been increased compared to 5 years ago.
LMAT has a worse debt/assets ratio than last year.
2.2 Solvency
LMAT has an Altman-Z score of 7.60. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
LMAT's Altman-Z score of 7.60 is amongst the best of the industry. LMAT outperforms 86.24% of its industry peers.
The Debt to FCF ratio of LMAT is 3.21, which is a good value as it means it would take LMAT, 3.21 years of fcf income to pay off all of its debts.
LMAT has a better Debt to FCF ratio (3.21) than 84.13% of its industry peers.
LMAT has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.46, LMAT perfoms like the industry average, outperforming 45.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Altman-Z | 7.6 |
ROIC/WACC0.9
WACC8.55%
2.3 Liquidity
A Current Ratio of 13.96 indicates that LMAT has no problem at all paying its short term obligations.
The Current ratio of LMAT (13.96) is better than 97.88% of its industry peers.
LMAT has a Quick Ratio of 11.74. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 11.74, LMAT belongs to the best of the industry, outperforming 95.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 |
3. Growth
3.1 Past
LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.78%, which is quite impressive.
LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
The Revenue has grown by 13.07% in the past year. This is quite good.
The Revenue has been growing by 13.41% on average over the past years. This is quite good.
EPS 1Y (TTM)26.78%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%53.06%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.76% yearly.
LMAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.67% yearly.
EPS Next Y19.93%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
EPS Next 5Y9.76%
Revenue Next Year13.86%
Revenue Next 2Y11.2%
Revenue Next 3Y10.46%
Revenue Next 5Y9.67%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 38.12, LMAT can be considered very expensive at the moment.
Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than 69.31% of the companies in the same industry.
LMAT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.89.
Based on the Price/Forward Earnings ratio of 34.90, the valuation of LMAT can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 71.96% of the companies listed in the same industry.
LMAT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 34.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.12 | ||
| Fwd PE | 34.9 |
4.2 Price Multiples
73.55% of the companies in the same industry are more expensive than LMAT, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, LMAT is valued a bit cheaper than 75.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.27 | ||
| EV/EBITDA | 24.45 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
LMAT has an outstanding profitability rating, which may justify a higher PE ratio.
LMAT's earnings are expected to grow with 12.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.91
PEG (5Y)2.23
EPS Next 2Y14.3%
EPS Next 3Y12.64%
5. Dividend
5.1 Amount
With a yearly dividend of 0.89%, LMAT is not a good candidate for dividend investing.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 1.89. LMAT pays more dividend than 92.06% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.89% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
LMAT has been paying a dividend for at least 10 years, so it has a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
LMAT pays out 34.45% of its income as dividend. This is a sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.45%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
88.44
-1.2 (-1.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.25%
Inst Owner Change-6.05%
Ins Owners7.8%
Ins Owner Change-9.35%
Market Cap2.00B
Revenue(TTM)240.87M
Net Income(TTM)47.12M
Analysts78.75
Price Target106.72 (20.67%)
Short Float %5.87%
Short Ratio7.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.89% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP34.45%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-5.52%
Max EPS beat(2)3.81%
EPS beat(4)2
Avg EPS beat(4)1.56%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.62%
EPS beat(12)8
Avg EPS beat(12)3.08%
EPS beat(16)8
Avg EPS beat(16)-1.76%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.79%
Max Revenue beat(2)1.83%
Revenue beat(4)3
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)-0.07%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.15%
PT rev (3m)0.12%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)5.11%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)5.92%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)2.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.12 | ||
| Fwd PE | 34.9 | ||
| P/S | 8.53 | ||
| P/FCF | 38.27 | ||
| P/OCF | 34.08 | ||
| P/B | 5.52 | ||
| P/tB | 7.6 | ||
| EV/EBITDA | 24.45 |
EPS(TTM)2.32
EY2.62%
EPS(NY)2.53
Fwd EY2.87%
FCF(TTM)2.31
FCFY2.61%
OCF(TTM)2.6
OCFY2.93%
SpS10.36
BVpS16.02
TBVpS11.64
PEG (NY)1.91
PEG (5Y)2.23
Graham Number28.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROCE | 10.02% | ||
| ROIC | 7.7% | ||
| ROICexc | 18.52% | ||
| ROICexgc | 32.83% | ||
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% | ||
| FCFM | 22.3% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Debt/EBITDA | 2.59 | ||
| Cap/Depr | 63.73% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.57% | ||
| Profit Quality | 111.05% | ||
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 | ||
| Altman-Z | 7.6 |
F-Score5
WACC8.55%
ROIC/WACC0.9
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)26.78%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%53.06%
EPS Next Y19.93%
EPS Next 2Y14.3%
EPS Next 3Y12.64%
EPS Next 5Y9.76%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year13.86%
Revenue Next 2Y11.2%
Revenue Next 3Y10.46%
Revenue Next 5Y9.67%
EBIT growth 1Y20%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year43.57%
EBIT Next 3Y22.42%
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y129.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
Can you provide the valuation status for LEMAITRE VASCULAR INC?
ChartMill assigns a valuation rating of 4 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 8 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 38.12 and the Price/Book (PB) ratio is 5.52.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 19.93% in the next year.